Related Experiment Videos

Prevalence and characterization of resistance to gentamicin in gram-negative bacteria

Microbios
|January 1, 1976
PubMed

Insights

Gentamicin resistance in Gram-negative bacteria increased threefold between 1974 and 1976, primarily in hospitalized patients. This resistance is often linked to specific enzymes and transferable plasmids.

Area of Science:

  • Microbiology
  • Bacterial genetics
  • Antimicrobial resistance

Background:

  • Gentamicin is a crucial antibiotic for treating Gram-negative bacterial infections.
  • Monitoring antibiotic resistance patterns is essential for effective clinical practice.

Purpose of the Study:

  • To investigate the prevalence of gentamicin resistance in clinical Gram-negative bacterial isolates.
  • To identify the mechanisms and genetic basis of gentamicin resistance.

Main Methods:

  • Survey of clinical isolates from 1974 and 1976.
  • Detection of gentamicin-inactivating enzymes.
  • Plasmid-mediated resistance transfer experiments.

Main Results:

  • A 3-fold increase in gentamicin resistance observed from 4% (1974) to 12% (1976).
  • Highest resistance rates in Serratia, Proteus inconstans, Klebsiella, Acinetobacter, and Pseudomonas.
  • Identified aminoglycoside 2''-adenylyltransferase, aminoglycoside 2'-N-acetyltransferase, and aminoglycoside 3-N-acetyltransferase in resistant strains.
  • Transferable plasmid-mediated resistance was confirmed in 8 of 16 resistant isolates.

Conclusions:

  • Significant rise in gentamicin resistance in Gram-negative bacteria, particularly in hospital settings.
  • Enzymatic inactivation and plasmid-mediated transfer are key mechanisms of gentamicin resistance.
  • Findings highlight the need for continued surveillance of antibiotic resistance.

Related Concept Videos